Design, Rational Repurposing, Synthesis, In Vitro Evaluation, Homology Modeling and In Silico Study of Sulfuretin Analogs as Potential Antileishmanial Hit Compounds
暂无分享,去创建一个
[1] Ki Duk Park,et al. Positional scanning of natural product hispidol’s ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases , 2022, Journal of enzyme inhibition and medicinal chemistry.
[2] Marco Biasini,et al. ProMod3—A versatile homology modelling toolbox , 2021, PLoS Comput. Biol..
[3] Yong Sup Lee,et al. Pyrrolidine-based 3-deoxysphingosylphosphorylcholine analogs as possible candidates against neglected tropical diseases (NTDs): identification of hit compounds towards development of potential treatment of Leishmania donovani , 2021, Journal of enzyme inhibition and medicinal chemistry.
[4] Jongki Hong,et al. Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids. , 2019, Bioorganic chemistry.
[5] Ki Duk Park,et al. First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent. , 2019, European journal of medicinal chemistry.
[6] Torsten Schwede,et al. SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..
[7] H. El Hajj,et al. Fatal Visceral Leishmaniasis Caused by Leishmania infantum, Lebanon , 2018, Emerging infectious diseases.
[8] T. Schwede,et al. Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology , 2017, Scientific Reports.
[9] D. Steverding. The history of leishmaniasis , 2017, Parasites & Vectors.
[10] Saikat Majumder,et al. Leishmania donovani-Induced Prostaglandin E2 Generation Is Critically Dependent on Host Toll-Like Receptor 2–Cytosolic Phospholipase A2 Signaling , 2016, Infection and Immunity.
[11] B. Shen. A New Golden Age of Natural Products Drug Discovery , 2015, Cell.
[12] A. Harvey,et al. The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.
[13] A. Ukil,et al. Prostaglandin E2 Negatively Regulates the Production of Inflammatory Cytokines/Chemokines and IL-17 in Visceral Leishmaniasis , 2014, The Journal of Immunology.
[14] Om Silakari,et al. Multifunctional compounds: smart molecules for multifactorial diseases. , 2014, European journal of medicinal chemistry.
[15] Jong Min Kim,et al. Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors. , 2014, Bioorganic & medicinal chemistry.
[16] S. Sundar,et al. Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani , 2013, Parasitology Research.
[17] A. Detsi,et al. Aurones: A Promising Heterocyclic Scaffold for the Development of Potent Antileishmanial Agents , 2012, International journal of medicinal chemistry.
[18] H. Esumi,et al. Mitochondrial fumarate reductase as a target of chemotherapy: from parasites to cancer cells. , 2012, Biochimica et biophysica acta.
[19] Kyung-Tae Lee,et al. Synthesis of aurones and their inhibitory effects on nitric oxide and PGE2 productions in LPS-induced RAW 264.7 cells. , 2011, Bioorganic & medicinal chemistry letters.
[20] Suman Gupta,et al. Visceral leishmaniasis: Experimental models for drug discovery , 2011, The Indian journal of medical research.
[21] Phil S Baran,et al. Aiming for the ideal synthesis. , 2010, The Journal of organic chemistry.
[22] P. Jaisankar,et al. Asymmetric synthesis of N-substituted N-hydroxyureas , 2008 .
[23] M. Nielsen,et al. Synthetic protocols and building blocks for molecular electronics , 2005 .
[24] Ming Chen,et al. Aurones Interfere with Leishmania major Mitochondrial Fumarate Reductase , 2002, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[25] L. Zhai,et al. Purification and enzymatic activity of an NADH‐fumarate reductase and other mitochondrial activities of Leishmania parasites , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[26] Ming Chen,et al. Inhibition of Fumarate Reductase inLeishmania major and L. donovani by Chalcones , 2001, Antimicrobial Agents and Chemotherapy.
[27] M. Olivier,et al. Leishmania donovani‐induced macrophages cyclooxygenase‐2 and prostaglandin E2 synthesis , 2001, Parasite immunology.
[28] O. Kayser,et al. In vitro leishmanicidal activity of aurones. , 1999, Planta medica.
[29] K. Santhamma,et al. Characterization of the respiratory chain of Leishmania donovani promastigotes. , 1995, Molecular and biochemical parasitology.